2014 Fiscal Year Final Research Report
Blood biomarker in malignant pleural mesothelioma
| Project/Area Number |
24390335
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (B)
|
| Allocation Type | Partial Multi-year Fund |
|---|
| Section | 一般 |
|---|
| Research Field |
Thoracic surgery
|
|---|
| Research Institution | University of Occupational and Environmental Health, Japan |
|---|
Principal Investigator |
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
URAMOTO Hidetaka 産業医科大学, 医学部, 准教授 (90389445)
SO Tomoko 産業医科大学, 医学部, 講師 (00331529)
YONEDA Kazue 産業医科大学, 医学部, 助教 (80724806)
HASEGAWA Seiki 兵庫医科大学, 医学部, 教授 (10252438)
ONAGA Takashi 富山工業技術センター, 中央研究所, 主幹研究員 (10416133)
|
|---|
| Project Period (FY) |
2012-04-01 – 2015-03-31
|
| Keywords | 悪性胸膜中皮腫 / バイオマーカー / 循環腫瘍細胞 / 循環内皮細胞 |
|---|
| Outline of Final Research Achievements |
Malignant pleural mesothelioma (MPM) is a highly aggressive tumor associated with asbestos exposure. The present study was conducted to develop useful biomarkers in the diagnosis of MPM. Among a variety of novel biomarkers tested, the most promising biomarker was circulating tumor cell (CTC) evaluated with a novel CTC-chip system, in which tumor cells were captured with micro-spots coated by a variety of antibodies. When an antibody against podoplanin, an antigen expressing on cell surface of MPM cells, was used as coating antibody, the CTC-chip provided a very high sensitivity in detection of MPM cells. Another progress in diagnostic biomarkers achieved in the present study was high sensitivity and specificity (79% and 76%, respectively) in discrimination between MPM and non-malignant pleural diseases with a combination of multiple biomarkers (CTC evaluated with the CellSearch SYSTEM, circulating endothelial cell [CEC], and serum mesothelin-related protein).
|
| Free Research Field |
呼吸器外科学
|
